XanaMIA Alzheimer's trial fully enrolledLikeFollowSharePublished 18 December 2025https://www.globenewswire.com/news-release/2025/12/18/3207671/0/en/Final-247th-participant-randomized-and-commences-treatment-in-Actinogen-s-XanaMIA-pivotal-phase-2b-3-Alzheimer-s-trial.htmlShare your feedbackQuestions (0)Post questionYour question will be sent privately to Actinogen. The company may choose to make this question public.Start the conversationAsk Actinogen a question about this update.DiscoverShare your feedbackDiscover
